NSEAnalysts/Institutional Investor Meet/Con. Call Updates3d ago · 16 Oct 2026, 07:15 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Beta Drugs Limited · BETA

✦ AI SummaryResults

Beta Drugs Limited has informed the Exchange about a scheduled earnings conference call to discuss Operational and Financial performance Q2 & H1 FY27 on Thursday, 22nd October, 2026 at 4:00 P.M. (IST).

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Beta Drugs Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

BETA_16102026191435_Concall_Intimation.pdf

pdf

Download →
View document text
BDL/PKL/SEC/2026-27 16th October, 2026 National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor Plot no. C/l, G Block Bandra-Kurla Complex, Bandra (E) Mumbai — 400 051. SYMBOL-BETA Sub.: Earnings conference call to discuss Operational and Financial performance Q2 & H1 FY27. Dear Sir, Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Management of our Company will be hosting an Earnings conference call to discuss Operational and Financial performance Q2 & H1 FY27 on Thursday, 22nd October, 2026 at 4:00 P.M. (IST). We are enclosing herewith the invitation to the conference call for reference. Thanking You Your’s faithfully For Beta Drugs Ltd. Rajni Brar Company Secretary Conference Call Invitation Q2 & H1FY27 Earnings Call PRIVATE CLIENT GROUP PhillipCapital (India) Private Limited cordially invites you to participate in Beta Drugs Ltd. Q2 & H1FY27 Earnings conference call to discuss operational and financial performance Speakers NSE: BETA | INE351Y01019 Mr. Rahul Batra – Chairman & Managing Director Bloomberg: BETADR IN Mr. Nipun Arora – Chief Financial Officer Mr. Ashutosh Shukla – Director (Sales & Marketing) Call Leader Thursday – 22nd October 2026 @ 04:00 PM IST Mr. Apurva Shah / Mr. Srisurya Kalagarla 06:30 PM Singapore & HK / 11:30 AM UK Pre-register to avoid wait time, join with DiamondPass Click Here to register Dial-In-Numbers Primary Number: +91 22 6280 1143/+91 22 7115 8044 The numbers listed above is universally accessible from all networks and all countries. Toll Free Number: USA: 18667462133 / UK: 08081011573 / Singapore: 8001012045 / Hong Kong: 800964448 #PhillipCapital (India) Private Limited remains committed to adhere to all regulatory guidelines and follow the best governance and transparency practices. Therefore: • The proceedings of this call will be recorded. • The list and full details of participants on the call will be shared by us with the corporate. Participants are expected to provide true and legitimate details. • All necessary disclosures on Stock Exchanges (including call invite intimation, recording details & call transcript) is expected to be complied by the respective corporate.